- Open Access
The protective or damaging effect of Tumor necrosis factor-α in acute liver injury is concentration-dependent
- Yulong Dong†1,
- Yuzhou Liu†1,
- Xingrui Kou†1,
- Yingying Jing1,
- Kai Sun1, 2,
- Dandan Sheng1,
- Guofeng Yu1,
- Dandan Yu1,
- Qiudong Zhao1,
- Xue Zhao1, 2,
- Rong Li1,
- Mengchao Wu1 and
- Lixin Wei1Email author
© Dong et al. 2016
- Received: 19 July 2015
- Accepted: 25 January 2016
- Published: 3 February 2016
Inflammatory cytokine is important in modulating injured diseases. Tumor necrosis factor-α (TNF-α), one of potent inflammatory cytokines, plays a dominant role in host defense reaction. However, the concrete effect of TNF-α on acute liver injury is totally unclear. Here we reported the concrete effect and possible mechanisms of TNF-α on acute liver injury induced by carbon tetrachloride (CCl4).
SD male rats were equally divided into nine groups. CCl4 (1 ml/kg) was subcutaneously injected into the rats. Enbrel, a TNF-α inhibitor, were intraperitoneally injected at dose of 0, 0.25, 0.5, 1, 2, 4 or 8 mg/kg 15 min before the CCl4 injection. 24 h later, rats were sacrificed. Serum ALT and AST were measured with an autoanalyzer. Serum TNF-α were measured by ELISA. HE staining was used to observe the liver tissue morphology. Hepatocellular apoptosis were tested by immunochemistry and Tunnel kit. Inflammatory factors, involve IL-4, IL-6, IL-8, IL-β and IFN-γ were detected by RT-PCR. The NF-κB signal pathway and anti-apoptotic genes include Bcl-XL, FHC, XIAP and Bcl-2 were measured by western-blotting and RT-PCR.
The change of liver function presented an obvious “V” shape in the whole process of persistently increased Enbrel. As Enbrel was increased gradually from 0 to 1 mg/kg, serum TNF-α were blocked, ALT and AST were gradually decreased as TNF-α as well as the numbers of hepatocellular apoptosis, and were declined to the minimum at 1 mg/kg Enbrel. As Enbrel was increased gradually from 1 to 8 mg/kg, ALT, AST and hepatocellular apoptosis were increased instead, and reached to the maximum at 8 mg/kg Enbrel. HE showed that the seriousness of hepatocellular steatosis was the most at 8 mg/kg Enbrel, and second at 0 mg/kg, the weakest at 1 mg/kg in the acute liver injury. Western-blotting and RT-PCR showed NF-κB, p-IκBα and antiapoptotic genes include Bcl-XL, FHC, XIAP, Bcl-2 were decreased as TNF-α was blocked by increased Enbrel.
Our results suggested that TNF-α had a dual role in acute liver injury. It was regulated might via the corporate effect of NF-κB signal pawahway and anti-apoptosis. Meanwhile, our findings provide a reference for clinical treatment of acute liver injury.
- Liver injury
Liver is a specialized organ in terms of its metabolic, synthetic and detoxifying function. It is a vulnerable organ as various noxious agents can be assimilated by intestine and transported into liver, inducing inflammation, necrosis, fibrosis, cirrhosis  and eventually hepatocellular carcinoma (HCC). Hepatic ischemia–reperfusion injury , endotoxemia , obstructive cholestasis , alcoholic hepatitis , halothane hepatitis , and hemorrhagic shock  can cause liver injury. Over 80 % of HCCs occur in patients with hepatic cirrhosis or fibrosis and thus develop in a setting of hepatocellular injury, regeneration, infiltration of inflammatory cells and an abundance of activated myofibroblasts . Despite different reasons, initiation of hepatocellular injury is the key to the common pathogenesis described previously, which in the long run promote the development of hepatic fibrosis and HCC . Unfortunately, at present, the exact mechanisms of liver injury are still under study and yet, the treatment for liver injury is still a big problem to human. Carbon tetrachloride (CCl4), a kind of hepatotoxin, can effectively duplicate liver injury model caused by its production of cytochrome P450 and the binding reaction with intermediate metabolites [10, 11]. It provides beneficial foundation for further studying liver injury.
However, in the pathological process of liver injury, numerous inflammatory cytokines are significantly upregulated, such as tumor necrosis factor-α (TNF-α), which mediate inflammation and repair in physiological conditions . Tumor necrosis factor-α is a multifunctional pro-inflammatory cytokine that regulates multifarious processes including inflammation, cellular apoptosis, coagulation, metabolism, insulin sensitivity, tumor growth and invasion, and vascular functions [13–17]. Normally, TNF-α is required for hepatocyte proliferation during liver regeneration induce the transcription factor nuclear factor-κB, which has protective effects . After injury, even when no infectious agents are present, TNF-α quickly migrate into the injured tissue after vasodilatation and suppress further cell death, activate stem cells, and promote epithelial proliferation . However, on the other hand, some literatures have reported TNF-α paly a malignant role in the injured liver. It triggers a series of intracellular events that result in activation of apoptosis and accelerating hepatic cells death during liver injury . And elevated serum levels of TNF-α in liver injured patients correlate with a detrimental prognosis [20, 21].
Despite current knowledge of TNF-α, litter is reported the concrete role of TNF-α in acute liver injury. Moreover, the influence of different concentration of TNF-α mediated by Enbrel (Etanercept), which is a genetically engineered fusion protein that can bind and inactivate TNF-α , on CCl4-induced acute liver injury remains largely unknown. Our present study is designed to determine the concrete effect of TNF-α on acute liver injured model induced by CCl4 and possible mechanisms associated with it.
TNF-α performs protective and harmful effects in CCl4-induced acute liver injury
The apoptosis of liver cells in acute liver injured rats
Internal concentration of TNF-α had influence on expression of inflammatory factors in CCl4-induced acute liver injury
TNF-α mediated acute liver injury may via NF-κB activation and subsequent production of anti-apoptotic genes
Many studies have focused on the role of TNF-α as a cytokine participate the occurrence and development of liver injury . Our present study provided experimental evidences that TNF-α performed protective and damaging effect at the same time in the CCl4-induced acute liver injury. For the protective side, our results demonstrated that the serum ALT and AST at 0 mg/kg Enbrel, a genetically engineered fusion protein which can specifically bind and inactivate TNF-α , is less than 8 mg/kg Enbrel (the highest level) in Fig. 1a, b. Hematoxylin and Eosin staining results also showed that the extent of hepatocellular steatosis was less at 0 than 8 mg/kg Enbrel (Fig. 1d). High level of serum TNF-α was detected at 0 mg/kg Enbrel, and very low level at 8 mg/kg Enbrel by Elisa in CCl4-induced liver injury (Fig. 1c). These results indicated that liver damage was slighter at 8 mg/kg Enbrel compared to the 0 mg/kg. Therefore, we believed that TNF-α had some protective effect in the CCl4-induced liver injury. For the damaging side, our results suggested that serum ALT and AST were decreased (Fig. 1a, b), as the Enbrel was added from 0 to 1 mg/kg in acute liver injury. And hepatocellular steatosis was also alleviated in this process. These results suggested that TNF-α also had some damaging effect in the CCl4-induced liver injury. Moreover, the protective effect seemed more prominent than the damaging effect at 0 mg/kg Enbrel.
On the account of apoptosis play a significant role in the injured tissues [26, 27], and is essential for clearance of potentially injurious inflammatory cells and subsequent efficient resolution of inflammation . Then, we next detected hepatocellular apoptosis at different levels of TNF-α in CCl4-induced liver injured rats. As expected, the number of apoptotic hepatocytes were prominently decreased as the level of TNF-α was slightly down-regulated, while elevated at both excessively low and high levels of TNF-α (Fig. 2a, b). Meantime, Western-Blotting (Fig. 2c) showed the similar result: the expression of hepatocellular apoptosis was weak at 1 mg/kg Enbrel, and strong at 0 than 8 mg/kg Enbrel. In addition, the expression of apoptosis was stronger at 8 than 0 mg/kg Enbrel. These data further demonstrated that TNF-α was an indispensable cytokine and played a dual role in acute liver injury. Interestingly, in our working, we found that the change of liver function presented an obvious “V” shape in the whole process of persistently increased Enbrel. We speculated that the declined speed of damaging effect of TNF-α was faster than the protective effect during the process of persistently increasing Enbrel in the CCl4-induced acute liver injury. Initially, as result of injurious hepatocytes stimulated by CCl4, TNF-α was recruited to repair damaged organization. However, too much TNF-α initiated hepatocytes damage instead. After Enbrel was increased gradually from 0 to 1 mg/kg, TNF-α were decreased (Fig. 1c), and its damaging effect had been receded as well as the protective effect. But the damaging effect was receded more than the protective effect. Relatively, the protective effect was prominent at the maximum when Enbrel was added at 1 mg/kg, which leaded to alleviate the whole extent of liver injury. As Enbrel was continually added from 1 to 8 mg/kg, the damaging effect and the protective effect of TNF-α were further receded. Yet, the extent of protective effect was decreased more than its damaging effect. Thus, its protective effect and damaging effect were declined to the maximum and were almost abolished at 8 mg/kg Enbrel. Therefore, the injurious hepatocytes caused by CCl4 at very low level of TNF-α were more serious than at high level. Because the protective effect of TNF-α was almost deficient.
However, acute injury is related with inflammatory responses , which accompany with the change of inflammatory factors level. To further investigate the reasons for the formation of “V” shape, we detected various pro-inflammatory factors including IL-6, IL-8, IL-1β, IFN-γ as well as anti-inflammatory factors IL-4 as TNF-α was blocked in CCl4-induced acute liver injury. RT-PCR indicated the mRNA expressions of IL-6, IL-8, IL-1β and IFN-γ were hardly influenced in the common rats no matter how much Enbrel were pretreated (Fig. 3). However, in the acute liver injured rats, these factors were subsequently decreased when TNF-α was blocked, while IL-4 had a completely adverse change. This because IL-4, as an anti-inflammatory factor, is secreted by Th2 cell , and can inhibit Th1 cell producing IFN-γ, IL-6, TNF-α et al. . Yet, relevant pro-inflammatory factors were decreased and meanwhile anti-inflammatory factors were correspondingly increased in the process of increasing Enbrel into CCl4-inducced rats. Therefore, we speculated that excessively inflammatory factors were recruited and destroyed the defensive system at 0 mg/kg Enbrel in acute CCl4-induced liver injured rats. Next, reduction of TNF-α could decline pro-inflammatory factors, then weakened hepatocytes damage from strong inflammatory response in acute injury. However, a certain concentration of inflammation is required for the activation of innate and adaptive immunity, which is essential for host defense [31, 32]. As TNF-α was blocked at high dose of Enbrel, pro-inflammatory factors were hardly detected. Although the damaging effect were almost abolished. But, the protective effect was also deficient, which might result in more serious hepatocellular damage. However, how did TNF-α and inflammatory factors exert the protective effect in the process of increasing Enbrel in the acute liver injury?
Some literatures have reported that the stimulation of TNF-α initiates a cascade of signaling events, which lead to the activation of NF-κB , whose signal pathway make an essential contribution to liver homeostasis and wound-healing processes [9, 33, 34]. Then, we further detected relative expressions of NF-κB and its subsequent productions by Western-Blotting in our study. It was excitedly that we discovered the expressions of NF-κB and subsequent production were gradually decreased as Enbrel was increased, and were hardly detected at 8 mg/kg Enbrel. Furthermore, our results showed that consistently down-regulated TNF-α concentration accompanied with declining of the expressions of antiapoptotic genes include Bcl-XL, FHC, XIAP, Bcl-2, all of which have protective effects. And their decreased extents were also dose-dependent on Enbrel. It indicated that NF-κB played a significantly role and its effect was gradually declined as well as anti-apoptotic genes, when the concentration of TNF-α was blocked by Enbrel in the CCl4-induced acute liver injury. Above of these findings, We speculated that the protective effect of TNF-α was emerged though NF-κB signal pathway, which further activated the antiapoptotic genes include Bcl-XL, FHC, XIAP, Bcl-2 et al., then take the protective role for the hepatocytes in the CCl4-induced acute liver injury. As TNF-α was blocked by Enbrel, its protective effect gradually decreased. In the initiate stage, subcutaneous injection of CCl4 into rats caused acute hepatocellular damage by its production of cytochrome P450 and the binding reaction with intermediate metabolites. Too much TNF-α and pro-inflammatory factors were recruited to the injured hepatocytes, then activated overexpression of NF-κB signal pathway, which further activated antiapoptotic genes to defend acute liver injury. As concentration of TNF-α was appropriately decreased from 0 to 1 mg/kg Enbrel, NF-κB was gradually weakened and the antiapoptotic genes were also activated slackly. However, the hepatocellular damage from CCl4 always existed as well as the damaging effect from TNF-α and inflammatory response. And the protective effect was a bit stronger than the damaging effect of TNF-α, meanwhile, its decreased speed was slower than the damaging effect. Thus, the whole of the hepatocellular damage was alleviated, and to the minimum at 1 mg/kg Enbrel. As the concentration of TNF-α was sequentially decreased from 1 to 8 mg/kg Enbrel, the protective effect from the NF-κB and antiapoptotic gene were continuously decreased. Meanwhile, the damaging effect resulted from TNF-α and inflammatory response was also weakened. In addition, the protective effect was declined faster than the damaging effect, and these effects were almost abolished at 8 mg/kg Enbrel. Thus, the hepatocellular damage was further aggravated at 8 mg/kg Enbrel, even was more serious than at 0 mg/kg Enbrel. Concurrently, the antiapoptotic genes were gradually down-regulated as TNF-α was consistently blocked by Enbrel (Fig. 4b, c), as result of the NF-κB was down-regulated. However, the hepatocellular damage induced by CCl4 was almost existed, and the damaging extent was the lightest at 1 mg/kg Enbrel, the most at 8 mg/kg Enbrel due to the change of the concentration of TNF-α. Thus, the number of apoptotic hepatocytes was the least at 1 mg/kg Enbrel, and the most at 8 mg/kg Enbrel (Fig. 2a, b). As the result of the protective effect of TNF-α, the hepatocellular apoptosis were slighter at 0 than at 8 mg/kg.
Our findings are clinically relevant, because moderately decrease internal TNF-α level can effectively protect liver from acute injury. But consistently down-regulated TNF-α level seems not a good choice for the treatment of acute liver injury. Meanwhile, present data shed novel mechanism on understanding different concentrations of role activating in acute liver injury caused by CCl4 and provide new conceptual information for therapeutic development of acute liver injury though properly reducing internal TNF-α level.
Animal models and treatment
All procedures involving animals were performed in accordance with the institutional animal welfare guidelines of Second Military Medical University and approved by the Ethics Committee of Eastern Hepatobiliary Surgery Hospital (Ethics Committee Approved Code:EHBHKY2012-002-7).
100 six weeks old Sprague–Dawley male rats (200–210 g) were purchased from Shanghai Experimental Animal Center of the Chinese Academy of Sciences, Shanghai, China. They were kept in ordinary cages at room temperature of 25 ± 3 °C with a 12 h dark/light cycles, and have free access to standard laboratory feed and water. To study the effects of TNF-α in acute injured rats, they were equally divided into nine groups (10 rats per group). CCl4 (1 ml/kg) was subcutaneously injected into Sprague–Dawley rats. Enbrel at dose of 0, 0.25, 0.5, 1, 2, 4 or 8 mg/kg was intraperitoneally administered to the CCl4-injected rats 15 min before the CCl4 injection. 24 h later, all the animals were weighted, sacrificed, collected the blood while livers were removed, weighted and perfuse in ice-cold saline solution. Liver samples were treated with liquid nitrogen and stored at −80 °C for further studies.
Serum ALT, AST and TNF-α assay
Serum activities of ALT and aspartate aminotransferase (AST) were measured with an autoanalyzer (Spotchem Co., Kyoto, Japan). Serum levels of TNF-α in rats were measured by enzyme-linked immunosorbent assay (ELISA) using the Immunotech Human TNF-α ELISA kit (Immunotech SAS, Marseille Cedex 9, France). The results are expressed as U/L.
Hematoxylin–eosin staining and TUNEL assay of liver sections
Liver tissues for histopathological examination were fixed with 10 % neutral buffered formalin, processed and trimmed, embedded in paraffin, sectioned to a thickness of approximately 5 μm, liver sections were stained with HE following standard protocol, then it was performed for light microscopic examination. TUNEL assay was performed using the In Situ Cell Death Detection kit (Roche Molecular Biochemicals).
Quantitatively measure the expression of cleaved caspase-3 by immunohistochemical staining. Liver tissues were fixed in Carnoy, embedded in paraffin, and sectioned at 5 μm. The sections of tissues were dewaxed and rehydrated with freshly distilled water. Samples underwent inactivation of endogenous peroxidase for 10 min and were washed with distilled water for 5 min (three times), then immersed in 0.1 mol/L citrate buffer solution (pH = 6.0) and heated in a microwave oven until boiling (twice, with a 5-minute interval). After washed with phosphate buffered saline, antigen-retrieval buffers were added for 10 min and tissues were then flushed three times with PBS. At room temperature, samples were non-specifically blocked with normal goat serum for 20 min. Sections were incubated overnight at 4 °C with rabbit anti-human cleaved caspase-3 antibody. Sections were washed in PBS and incubated at room temperature for 10 min with biotinylated goat anti-rabbit IgG. After washing with PBS, sections were incubated with streptavidin-peroxidase for 10 min and then stained with diaminobenzidine for 10 min and washed for 5 min. Samples were stained with hematoxylin, and were dehydrated and mounted for microscopic examination. Images of the sections were obtained using the Image-Pro Plus 4.5 software (Media Cybernetics, Silver. Spring, USA) with brown staining under light microscopy indicating a positive reaction of cleaved caspase-3.
Total soluble proteins extraction from liver tissue and western-blot analysis were performed as described. Antibodies used in western-blot experiments were specific for cleaved caspase-3, IκBα (inhibitor of NF-kappa B-α), p-IκBα (Phospho-IκBα), BCL-2 (B cell leukemia/lymphoma 2), BCL-XL (B-cell lymphoma-extra large), XIAP (X-linked Inhibitor of Apoptosis Protein), FHC (Ferritin heavy chain), β-actin and goat anti-rabbit secondary antibody were obtained from Cell Signaling Technology. NFκB-p65 antibody was obtained from Abcam.
The transcript levels of FHC, Bcl-XL, Bcl-2, XIAP, TNF-α, IL-1β, IFN-, IL-6, IL-8 and IL-4 in liver tissues of rats were measured using RT-PCR technique. Total RNA was isolated using the TriPure reagent (Roche Diagnostics), RNA concentrations and purity were determined by measuring the absorbance A260–A280 nm ratio. The relative quantities of mRNAs were obtained by using the comparative Ct method and were normalized with glyceraldehydes-3-phosphate dehydrogenase (GAPDH). The primer sequences were as following: FHC: Forward primer 5′-CCACGTGACCAACTTACGC-3′, Reverse primer 5′-AGTCAGCTTATCTCTCATCACCG-3′; Bcl-XL: Forward primer 5′-TCCCTTCAGAACCTTATCTTGG-3′, Reverse primer 5′-TCCCGGAAGAGTTCATTCAC-3′; Bcl-2: Forward primer 5′-ACAGCCAGGAGAAATCAAA-3′, Reverse primer 5′-GTCGCTACCGTCGTGACTTC-3′; XIAP: Forward primer 5′-CTGCATTGCATTCCATTAGC-3′, Reverse primer 5′-TGCTTCTCTGTCTAAGGTTTCAA-3′; TNF-α: Forward primer 5′-TTCTGTCTACTGAACTTGGGGGTGATCGGTCC-3′, Reverse primer 5′-GTATGAGATAGCAAATCGGCTGACGGTGTGGG-3′; IL-1β: Forward primer 5′-GGCTGCTTCCAAACCTTTGA-3′, Reverse primer 5′-GAAGACACGGATTCCATGGT-3′; IL-6: Forward primer 5′-ATGAAGTTCCTCTCTGCAAGAGAC-3′, Reverse primer 5′-CACTAGGTTTGCCGAGTAGATCTC-3′; IL-8: Forward primer 5′-AATTCTCGAGTCGCGAATGGCTGCTCAAGGCTG-3′, Reverse primer 5′-ATTACGGCCGTCGCGATTAGGCATCACTGCCTG-3′.
All data are presented as mean ± SEM. Groups were compared by analysis of variance (ANOVA) with a posteriori contrast by least significant difference. For all analyses, p < 0.05 was considered statistically significant.
YLD analyzed the data and participated in the writing of the manuscript; YZL and YYJ corrected the manuscript; XRK and KS designed and performed experiments and corrected the manuscript; DDS participated in revising the manuscript; GFY, DDY, QDZ, XZ and RL participated in designing and performing experiments; MCW and LXW designed experiments and finalized the manuscript. All authors read and approved the final manuscript.
This project was supported by Key project of National Natural Science Foundation of China (Grant No. 81030041); National Natural Science Foundation of China (Grant No. 31171321, 81101622, 81201584); Special Funds for National key Sci-Tech Special Project of China (Grant No. 2012ZX10002-016, 2012ZX10002011-011); Shanghai Science and Technology Committee (Grant No. 12431900802, 12ZR1439800, 12ZR1454200); Shanghai Municipal Education Commission (Grant No. 14ZZ086).
The authors declare that they have no competing interests.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- Aldaba-Muruato LR, et al. Protective effects of allopurinol against acute liver damage and cirrhosis induced by carbon tetrachloride: modulation of NF-kappaB, cytokine production and oxidative stress. Biochim Biophys Acta. 2012;1820(2):65–75.View ArticlePubMedGoogle Scholar
- Jaeschke H, et al. Functional inactivation of neutrophils with a Mac-1 (CD11b/CD18) monoclonal antibody protects against ischemia-reperfusion injury in rat liver. Hepatology. 1993;17(5):915–23.View ArticlePubMedGoogle Scholar
- Jaeschke H, Farhood A, Smith CW. Neutrophil-induced liver cell injury in endotoxin shock is a CD11b/CD18-dependent mechanism. Am J Physiol. 1991;261(6 Pt 1):G1051–6.PubMedGoogle Scholar
- Gujral JS, et al. Neutrophils aggravate acute liver injury during obstructive cholestasis in bile duct-ligated mice. Hepatology. 2003;38(2):355–63.View ArticlePubMedGoogle Scholar
- Bautista AP. Neutrophilic infiltration in alcoholic hepatitis. Alcohol. 2002;27(1):17–21.View ArticlePubMedGoogle Scholar
- You Q, et al. Role of neutrophils in a mouse model of halothane-induced liver injury. Hepatology. 2006;44(6):1421–31.View ArticlePubMedGoogle Scholar
- Jaeschke H. Reactive oxygen and mechanisms of inflammatory liver injury: present concepts. J Gastroenterol Hepatol. 2011;26(Suppl 1):173–9.View ArticlePubMedGoogle Scholar
- Okuda K. Hepatocellular carcinoma. J Hepatol. 2000;32(1 Suppl):225–37.View ArticlePubMedGoogle Scholar
- Luedde T, Schwabe RF. NF-kappaB in the liver–linking injury, fibrosis and hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol. 2011;8(2):108–18.PubMed CentralView ArticlePubMedGoogle Scholar
- Bruckner JV, et al. Mechanisms of circadian rhythmicity of carbon tetrachloride hepatotoxicity. J Pharmacol Exp Ther. 2002;300(1):273–81.View ArticlePubMedGoogle Scholar
- Yin M, et al. Essential role of tumor necrosis factor alpha in alcohol-induced liver injury in mice. Gastroenterology. 1999;117(4):942–52.View ArticlePubMedGoogle Scholar
- Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 1995;108(6):1849–54.View ArticlePubMedGoogle Scholar
- Ji H, et al. TNFR1 mediates TNF-alpha-induced tumour lymphangiogenesis and metastasis by modulating VEGF-C-VEGFR3 signalling. Nat Commun. 2014;5:4944.View ArticlePubMedGoogle Scholar
- Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer. 2009;9(5):361–71.View ArticlePubMedGoogle Scholar
- Johnstone RW, Frew AJ, Smyth MJ. The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat Rev Cancer. 2008;8(10):782–98.View ArticlePubMedGoogle Scholar
- Nicholson DW. From bench to clinic with apoptosis-based therapeutic agents. Nature. 2000;407(6805):810–6.View ArticlePubMedGoogle Scholar
- Varfolomeev EE, Ashkenazi A. Tumor necrosis factor: an apoptosis JuNKie? Cell. 2004;116(4):491–7.View ArticlePubMedGoogle Scholar
- Bradham CA, et al. Mechanisms of hepatic toxicity. I. TNF-induced liver injury. Am J Physiol. 1998;275(3 Pt 1):G387–92.PubMedGoogle Scholar
- Kuraishy A, Karin M, Grivennikov SI. Tumor promotion via injury- and death-induced inflammation. Immunity. 2011;35(4):467–77.PubMed CentralView ArticlePubMedGoogle Scholar
- An F, et al. miR-15b and miR-16 regulate TNF mediated hepatocyte apoptosis via BCL2 in acute liver failure. Apoptosis. 2012;17(7):702–16.View ArticlePubMedGoogle Scholar
- Streetz K, et al. Tumor necrosis factor alpha in the pathogenesis of human and murine fulminant hepatic failure. Gastroenterology. 2000;119(2):446–60.View ArticlePubMedGoogle Scholar
- Weinblatt ME, et al. A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med. 1999;340(4):253–9.View ArticlePubMedGoogle Scholar
- Stocker CJ, et al. TNF-alpha, IL-4, and IFN-gamma regulate differential expression of P- and E-selectin expression by porcine aortic endothelial cells. J Immunol. 2000;164(6):3309–15.View ArticlePubMedGoogle Scholar
- Ding J, et al. Genome-wide screening reveals that miR-195 targets the TNF-alpha/NF-kappaB pathway by down-regulating IkappaB kinase alpha and TAB 3 in hepatocellular carcinoma. Hepatology. 2013;58(2):654–66.View ArticlePubMedGoogle Scholar
- Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51):6680–4.View ArticlePubMedGoogle Scholar
- Sun C, Fan JG, Qiao L. Potential epigenetic mechanism in non-alcoholic fatty liver disease. Int J Mol Sci. 2015;16(3):5161–79.PubMed CentralView ArticlePubMedGoogle Scholar
- McGrath EE, et al. TNF-related apoptosis-inducing ligand (TRAIL) regulates inflammatory neutrophil apoptosis and enhances resolution of inflammation. J Leukoc Biol. 2011;90(5):855–65.PubMed CentralView ArticlePubMedGoogle Scholar
- Rossi AG, et al. Cyclin-dependent kinase inhibitors enhance the resolution of inflammation by promoting inflammatory cell apoptosis. Nat Med. 2006;12(9):1056–64.View ArticlePubMedGoogle Scholar
- Jaeschke H. Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Physiol Gastrointest Liver Physiol. 2006;290(6):G1083–8.View ArticlePubMedGoogle Scholar
- Navikas V, Link H. Review: cytokines and the pathogenesis of multiple sclerosis. J Neurosci Res. 1996;45(4):322–33.View ArticlePubMedGoogle Scholar
- Do-Umehara HC, et al. Suppression of inflammation and acute lung injury by Miz1 via repression of C/EBP-delta. Nat Immunol. 2013;14(5):461–9.PubMed CentralView ArticlePubMedGoogle Scholar
- Sun SC. Deubiquitylation and regulation of the immune response. Nat Rev Immunol. 2008;8(7):501–11.View ArticlePubMedGoogle Scholar
- Bettermann K, et al. TAK1 suppresses a NEMO-dependent but NF-kappaB-independent pathway to liver cancer. Cancer Cell. 2010;17(5):481–96.View ArticlePubMedGoogle Scholar
- Inokuchi S, et al. Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesis. Proc Natl Acad Sci U S A. 2010;107(2):844–9.PubMed CentralView ArticlePubMedGoogle Scholar